ISLE OF MAN MEDICAL SOCIETY
PRESS RELEASE | FOR IMMEDIATE RELEASE: THURSDAY, 19th NOVEMBER 2026
Isle of Man Medical Society Calls for Inpatient Bed Expansion, Stronger Clinical Leadership, and Investment in Local Services Following 2025/26 Manx Care Assessment
Doctors welcome frontline achievements in the DHSC annual assessment (GD No. 2026/0103) while setting out a constructive, phased roadmap to address inpatient capacity pressures, waiting times, and reliance on external providers.
DOUGLAS, ISLE OF MAN — 19 November 2026 — The Isle of Man Medical Society (IoMMS) has published its formal response to the Department of Health and Social Care’s (DHSC) Assessment of Manx Care for 2025/26 (Government Document No. 2026/0103). The Society welcomes the report’s recognition of frontline healthcare staff while highlighting persistent structural challenges in inpatient capacity, timely access to diagnostics and treatment, and clinical governance.
The Society commends doctors, nurses, and allied health professionals across the Island for delivering a 92.4% positive Friends and Family Test rating, zero neonatal deaths, improved infection prevention, and a more than 50% reduction in delayed transfers of care (down from 194 to 81). At the same time, the assessment underscores long-standing concerns raised by the Noble’s Hospital Medical Staff Committee regarding underlying inpatient bed capacity and system flow.
“The Department’s assessment confirms that Noble’s Hospital faces a structural shortage of physical inpatient beds, rather than solely a discharge challenge. Even with delayed transfers of care more than halved, adult acute bed occupancy reached 87.8%, 14.1% of admitted patients waited over 12 hours for a ward bed, and the hospital spent 174 days at OPEL Level 3. Expanding staffed inpatient capacity and embedding clinical leadership in decision-making are essential next steps.”
Key Areas Highlighted by the Isle of Man Medical Society
· Supporting Local Surgical Teams Over Costly External Outsourcing: The Society expresses concern over the high-cost engagement of external private surgical providers where local services have been adversely affected—including instances where theatre sessions for local surgeons were cancelled to accommodate visiting external teams. Rather than relying heavily on external private contracts and management consultancies, the Society urges Manx Care and the DHSC to protect local theatre lists and replicate the proven working practices of on-Island specialties that already maintain short waiting times.
· Cancer and Diagnostic Waiting Times: Against an 11.2% increase in suspected cancer referrals, performance against all three cancer waiting time standards remained below target, with 62-day referral-to-treatment performance moving from 51.9% to 47.1% (against a 75% target) and 28-day Faster Diagnosis standing at 64.0% (target 80%). Meanwhile, 68.3% of patients waited six weeks or more for a radiology scan (target ≤1%, compared with 10–22% in NHS England), and waiting time data for endoscopy and other non-radiology diagnostics is not yet captured in public reporting.
· Elective Backlog and Information Systems: At year-end, 14,883 unique patients were waiting an average of 56 weeks for a first consultant-led outpatient appointment, while theatre utilisation stood at 80.1% due in part to acute medical pressures on surgical beds. The Society notes the urgent need to upgrade the Patient Administration System, so clinicians have reliable end-to-end referral-to-treatment and maximum waiting time visibility.
· Funding Timelines, Financial Sustainability, and Workforce Planning: Delays in approving transformation funding—submitted in July 2025 and confirmed by Treasury in February 2026—restricted in-year progress on outpatient validation (9.7% of target), virtual wards, and follow-up pathway reforms. Manx Care ended the year with a £14.9 million operational deficit, reflecting a £10.1 million variance in temporary bank, locum, and agency staffing costs, while the mandated £500,000 reduction in Noble’s Hospital management and administration costs was not achieved.
· Maintaining Doctor-Led Primary Care: General Practice delivered increased appointment volumes (367.8 per 1,000 weighted patients) with lower non-attendance (3.8%). The Society welcomes the fact that 57% of community consultations continue to be delivered by qualified General Practitioners. This is an important safeguard for diagnostic safety and continuity of care—and advises that Shared Care Agreements, piloted with two patients in 2025/26, be expanded only with dedicated funding and specialist support.
· Workforce Morale and Engagement: The Society encourages the DHSC and Manx Care to address the findings of the BMA’s February 2026 Culture of Care Barometer survey—which showed fewer than a quarter of responding doctors would recommend Manx Care as a place to work—by strengthening visible senior leadership and regular board-to-clinician dialogue.
“Sustainable recovery depends on investing in our own Island workforce, protecting local surgical lists, and ensuring doctors have a meaningful voice in service design and resource allocation. Our phased roadmap offers practical, evidence-based steps to improve patient flow, reduce reliance on temporary staffing, and deliver better value for public money.”
A Phased Roadmap for Improvement
The Society’s submission outlines 16 practical recommendations across immediate (0–6 months), medium-term (6–18 months), and long-term (18+ months) horizons, inviting Tynwald, the DHSC, and Manx Care to:
· Expand staffed inpatient ward capacity at Noble’s Hospital alongside establishing a dedicated Clinical Decision Unit (CDU) and fully staffing Phase 2 of the Ambulatory Assessment and Treatment Unit (AATU).
· Prioritise local surgical teams and internal best practice by ring-fencing elective surgical beds and local theatre lists from displacement and sharing workflow efficiencies from on-Island specialties with short waiting times.
· Establish a formal Professional Executive Committee (PEC) and elected medical advisory structure to embed frontline clinical expertise in bed planning, service redesign, and resource allocation.
· Conduct an independent review of management and administrative expenditure to cap overhead costs at 5–6% of the health budget and reinvest savings into substantive medical, nursing, and GP recruitment.
· Progress the single Electronic Patient Record (Manx Care Record) and Electronic Prescribing across primary and secondary care, supported by multi-year capital and transformation planning.
— ENDS —
Notes to Editors
1. Full IoMMS Response: The Isle of Man Medical Society’s full submission, Response to the Department of Health and Social Care’s Assessment of Manx Care for 2025/26 (Reference: GD No. 2026/0103), is available upon request.
2. About the Isle of Man Medical Society (IoMMS): The Isle of Man Medical Society is the independent professional representative body for doctors working across primary, secondary, and community healthcare on the Isle of Man, dedicated to advancing clinical standards, patient safety, and sustainable healthcare governance.
3. Media Enquiries: Executive Committee, Isle of Man Medical Society | Email: secretary@iomms.org |